Curriculum Vitae - Dr Kenneth John HARVEY

Contact Details Medreach Pty. Ltd. 35a Mary St. Hawthorn, Victoria, 3122, Australia Mobile: +61 4 1918 1910, VOIP: 03 9029 3697 E-mail: [email protected] and [email protected] WWW: https://www.medreach.com.au/ Date of Birth 26th June, 1944 Marital Status Married (Dr Jenny Harvey); three adult children, all university graduates, 4 grandchildren. Qualifications MB BS (1967); FRCPA (1975); MASM (1984) Current Medical Board of Australia Registration (Teaching and Assessing): MED0000996411. Current Position Honorary Adjunct Associate Professor, Bond University President, Fiends of Science in Medicine Director, Medreach Pty. Ltd. Special Interests Health Services Research, specifically: • Therapeutic Goods and Services Policy and Regulation (including Complementary Therapies) o Quality of goods and services o Equity of access o Viable and responsible industry (Ethical promotion) o Quality of use (Rational use) • Science advocacy o Friends of Science in Medicine • Consumer advocacy o Choice (Australian Consumer Association) o Consumers Health Forum. Professional • Member of the group of experts that devised the 1988 World Health Organization, Ethical Achievements Criteria for Medicinal Drug Promotion • Founding member, and at various times author, Chair of Antibiotic Writing Group and Board Member of Therapeutic Guidelines Limited • Inaugural member of the PHARM committee that devised the Quality Use of Medicines (QUM) plank of Australian Medicinal Drug Policy • Awarded life membership of CHOICE (Australian Consumers' Association) for services to the consumer movement (also CHOICE 2012 Consumer champion) • Awarded life membership of the Australian Skeptics for recognition of relentless campaigning against schlocky medical products and claims. • Chair of the Governing Council of Health Action International, Asia Pacific (HAIAP) • Awarded ANZAAS Medal 2016. For contribution to science which go beyond normal professional activities • Awarded Member (AM) in the General Division of the Order of Australia, 2017 for significant service to community health and the pharmaceutical industry through roles in developing guidelines for the ethical use of antibiotics • Elected President, Friends of Science in Medicine, 2019. Previous • Resident Medical Officer, Port Moresby General Hospital, Territory of Papua & New Positions Guinea, (1968) • Pathology Registrar (Microbiology), The Prince Henry and Prince of Wales Hospital Group, Sydney, (1969-72) • Registrar in Medical Computing, New South Wales Health Department -The Prince Henry and Prince of Wales Hospital Group, Sydney (1973) • Trainee in Microbiology, Victorian Hospitals and Charities Commission (1974-75) • Medical Clinical Assistant, The Royal Melbourne Hospital, (1975-76) • Assistant Microbiologist, The Royal Melbourne Hospital (1976-84) • Director of Microbiology, The Royal Melbourne Hospital (1984-87) • External Drug Evaluator, Therapeutic Goods Administration (1985-91) • Senior Lecturer, School of Public Health, La Trobe University (1990-2005) • Honorary Senior Research Fellow, School of Information Technology & Mathematical Sciences, University of Ballarat (2001-2010) • Adjunct Senior Lecturer, School of Public Health, La Trobe University (2006-2011) • Adjunct Associate Professor, School of Public Health, La Trobe University (2012-2014)

Page 1 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Australian Director, AusAID Philippines National Drug Policy Cooperation Project (1993-97) • Board Member, Therapeutic Guidelines Limited (1997-2004) • WHO Fellow: Rational Drug Use - Malaysia, Bangladesh, China (2000) • Council Member, Australian Consumers Association (2000-2005) • Consultant, Australian Health Insurance Commission (now Medicare Australia): Croatian and Jordan Pharmaceutical Reform (2003-2006) • Consultant, USAID-PHRplus: Jordan Pharmaceutical Reform (2005-06) • Consultant, Medicare Australia. An Economic & Equity Impact Review of Australian National Pharmaceutical System Models. Pharmaceutical Reform Working Group Steering Committee (2006) • Adjunct Senior Lecturer, School of Public Health, La Trobe University (2006-2011) • Adjunct Associate Professor, School of Public Health, La Trobe University (2012- 2014) • Adjunct Associate Professor, School of Public Health and Preventive Medicine, Monash University (2014-2016) • Assoc Professor, School of Public Health and Preventive Medicine, Monash University (2017-2020). Overseas Bangladesh, China, Croatia, Hong Kong, India, Indonesia, Jordan, Laos, Malaysia, Experience Pakistan, Papua & New Guinea, Philippines, Singapore, Sri Lanka, Thailand, Vietnam. Committees • NH&MRC Medical Research Committee. (Past) • Therapeutic Goods Administration, Laboratory Advisory Committee. • Therapeutic Goods Advertising Code Council (Media Council of Australia). • Pharmaceutical Health and Rational Use of Medicines (PHARM) Committee, PHARM- Industry group and PHARM-Evaluation subcommittee of the Commonwealth Department of Community Services and Health. • WHO Expert Working Party that devised Ethical Criteria for Medicinal Drug Promotion • Organising Committee, International Conference on National Medicinal Drug Policies (WHO-Australian Government) 1995 • International Coordinating Committee, People's Health Assembly 2000 • Commonwealth Immunisation E-Handbook (8th edition) Working Party • General Practice Computer Group, Chronic Disease Management Working Group (2004- 2005). • Organising Committee, HAIAP, National Workshop on Rational Use of Antibiotics in China (2005) • Co-Chair, IT14-2-1, Standards Australia Pharmacy Concept Terminology (2005-2008). • Member, Research and Development Working Group and Electronic Prescribing Study Guidance Group, Australian National Prescribing Service (2006-11) • Member, Policy Advisory Group, Australian Consumers Association (2006-2012) • Member, Australian Government Working Group on Promotion of Therapeutic Products (2010-2011) • Member, Therapeutic Goods Administration Transparency Review Panel, (2010-2011) • Member, Scientific Program Committee, Asia Pacific Conference on National Medicines Policies 2012. • Chair, Governing Council, Health Action International Asia Pacific (2010-2013) • Member, Therapeutic Goods Administration, Business Process Reform CEO Forum (2011-2013) • Member, Australian Government Working Group on Regulatory Reform of Complementary Medicines (2011-2013) • Government’s Natural Therapy Review Advisory Committee (representing the Consumer Health Forum) (2013-2014) • Medicines Australia Code Review Panel (representing consumer interests) (2013-2014) • RACP Ethical Guidelines Working Party (2011-2014). • Choice representative on the Therapeutic Goods Advertising Consultative Council 2019- 2020. Past Board • 2000-2005: Australian Consumers Association Memberships: • 1997-2004: Therapeutic Guidelines Limited.

Page 2 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

Current • Choice - Australian Consumers Association (Life member). Membership of • Australian Skeptics (Life member) Organisations & • Consumers Health Forum. Professional • Friends of Science in Medicine (President) Societies • Health Action International - Asia Pacific (HAIAP) • Public Health Association of Australia • Doctors for the Environment Australia. Publications • PHARM Evaluation Sub-committee (Gilbert A, Brooks C, Corti B, Harvey K, Harvey R, Books James M, Murray M, Primrose J, Swift D.) Manual of Indicators to measure the effect of initiatives under the Quality Use of Medicine arm of the National Medicinal Drug Policy. Australian Government Publishing Service, Canberra 1995. • Harvey KJ (Chairman), Beavis M, Christiansen K, Collignon P, Currie B, Dartnell J, Ferguson J, Harkness J, Isaacs D, Khariwala B, Kucers A, Looke D, Spicer WJ, Tosolini FA, Turnidge J. Antibiotic Guidelines 10th Ed. Therapeutic Guidelines Ltd., Melbourne 1998 (and also involvement in the first edition and a number of previous editions). • Roughead EE, Gilbert AL, Primrose JG, Harvey KJ, Sansom LN. Report of the national indicators: Evaluating the quality use of medicines component of Australia's National Medicines Policy. Publications Production Unit, Commonwealth Department of Health and Aged Care, Canberra, 1999. Book chapters • Harvey K, Murray M. Medicinal drug policy, in The Politics of Health, 2nd Ed., Gardner H (Ed) Churchill Livingstone, Melbourne, 1995, 238-283. • Harvey KJ. Drug Promotion, in Drugs in the Health Marketplace. Komesaroff PA, Wiltshire J. (Ed) Arena Publications, Melbourne 1997, 47-70. • Aroni R, de Boer R, Harvey K. The Viagra Affair. In Evidence-based Health Policy, Edited by Lin V & Gibson B. Oxford University Press, Melbourne 2003, 97-109. • Löfgren H, Harvey K. The Pharmaceutical Benefits Scheme, in Understanding the Australian Health Care System, 2nd Ed. Willis E, Reynolds L, Keleher H. (Ed) Churchill Livingstone Elsevier, Sydney, (publication date: early 2012). • Harvey K. Regulation of Complementary Medicines, in Perspectives on complementary and alternative medicines, Edited by Prof Ian Olver & Monica Robotin, Imperial College Press, Oct 2011. Editorials • King K, Harvey K. MRSA Revisited (Editorial). Med J Aust 1985; 2: 88-89. • Darvall L, Harvey KJ Australian pharmaceutical advertising: a critique (Editorial). Med J Aust 1985; 2:272-274. • Harvey K. Quality assurance of therapeutic products and practice (Editorial). Med J Aust 1987; 147: 317. • Harvey K, Rogers S, Roughead L. Initiatives to improve antibiotic use (Editorial). Aust Presc 1999; 22: 26-28. • Harvey K. Controlling complementary medicine claims (Editorial). Aust Prescr 2008; 31: 142-3. • Harvey KJ, Day RO, Campbell WG, Lipworth L. Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration? MJA Rapid Online Publication — 6 May 2011. • Harvey K. Transparency and the Therapeutic Goods Administration. Aust Prescr 2013; 36:110-1. • Harvey K, Diug B. Editorial: Retail Genetics. Aust Prescr 2017; 40:86-7 • Harvey, K. (2017), Regulation of complementary medicines. Intern Med J, 47: 983–985. • Harvey K, Diug B. Editorial: The value of food fortification as a public health intervention. Med J Aust 2018; 208 (3): 111-112. Articles in • Harvey KJ, Smith DD. Antimicrobial sensitivity patterns as a guide to the domiciliary referred journals treatment of urinary tract infections. Med J Aust 1972; 1: 177-8. • Harvey KJ. Antibacterial activity in urine. Med J Aust 1972; 1: 1072-4. • Bell SM, Harvey KJ, Smith DD Double-blind trial comparing trimethoprim- sulphamethoxazole (Bactrim) with ampicillin in treating urinary infections. Med J Aust 1972; 1: 442. • Harvey KJ, Were M, Heys, Wendy, Smith DD. A time-shared computer system for data processing in bacteriology. Med J Aust 1972; 2: 1076.

Page 3 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Murnaghan GF, Tynan AP, Farnsworth RH, Harvey K. Chronic prostatitis--an Australian view. Br J Urol 1974 ;46:55-59. • Harvey K, Bishop L, Silver D, Jones T. A case of chancroid. Med J Aust 1977; 1:956- 957. • Harvey K, Schuck S. Acinetobacter septicaemia following prolonged intravenous therapy. Med J Aust 1977; 2:121-124. • Harvey KJ, Miles H, Hurse A, Carson M. In-vitro activity of erythromycin against anaerobic microorganisms. Med J Aust 1981; 1: 474-475. • Harvey K, Pavillard R. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains. Med J Aust 1982 May 29; 465-7. • Pavillard R, Harvey K, Douglas D, Hewstone A, Andrew J, Collopy B, Asche V, Carson P, Davidson A, Gilbert G, Spicer J, Tosolini F. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1982; 1: 451-454. • Harvey K. Promotion of newer antimicrobial agents. Med J Aust 1983; 1: 27-8; • Harvey K, Stewart R, Hemming M, et al. Use of antibiotic agents in a large teaching hospital. The impact of Antibiotic Guidelines. Med J Aust 1983; 2: 217-2. • Harvey KJ, Stewart R, Hemming M, Naismith N, Moulds RF. Educational antibiotic advertising. Med J Aust 1986; 1: 28-32. • Avorn J, Harvey K, Soumerai SB, et al. Information and education as determinants of antibiotic use: Report of Task Force 5. Rev Infect Dis 1987; Suppl 3: S286-96. • Graves SR, Rosengren NJ, Kennelly-Merrit SA, Harvey KJ, Thornton IW. Antibiotic- resistance patterns and relative concentrations of bacteria (gram-negative rods) from ash deposits of various ages on the Krakatau islands. Philos Trans R Soc Lond B Biol Sci 1988; 322: 327-37 • Landgren FT, Harvey KJ, Mashford ML, et al. Changing antibiotic prescribing by educational marketing. Med J Aust 1988; 149: 595-9. • Harvey KJ. Antibiotic use in Australia. Aust Presc 1988; 11: 74-77. • Harvey K. Australia: Pharmaceutical Benefits Scheme. Lancet 1991; 337: 418-419. • De Santis G, Harvey KJ, Howard D, et al. Improving the quality of antibiotic prescriptions in general practice. The role of educational intervention. Med J Aust 1994; 1: 502-5. • Williams D, Chiu E, Harvey K. Does admission to a hospital geriatric psychiatry programme improve benzodiazepine and other drug use? Int J Geriatr Psychiat 1994; 9: 501-505. • Roughead EE, Gilbert AL, Harvey KJ. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners? Int J Health Serv 1998; 28: 269-279. • Roughead EE, Harvey KJ, Gilbert AL. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Aust NZ J Med 1998; 28: 306- 310. • Nolan AM, Norquay CA, Dartnell JGA, Harvey KJ. Electronic prescribing and computer-assisted decision support systems. MJA 1999; 171: 541-543. • Harvey K. Medication management 2000: e-Scripts, e-Promotion. e-Health? Health Issues 2000; 63: 10-14. • Harvey Ken. Australian E-Health Policy: Once was Rational? Health Issues 2001: 67; 11- 14. • Roughead EE, Monteith GR, Harvey KJ and Tett SE. Evaluating Australia's National Medicines Policy using Geographical Mapping. Internal Medicine Journal. 2002: 3; 66- 72. • Phanouvong S, Barraclough S, Harvey K. Improving primary health care in Thailand: The role of the National Medicinal Drug Policy. Aust J Primary Health 2002: 8; 24-30. • Harvey K, Dartnell J, Hemming M. Improving antibiotic use: 25 years of antibiotic guidelines and related initiatives. Commun Dis Intell 2003; 27 Suppl: S9–S11. • Lewis B, Harvey K, Dartnell J, Shepheard J. Modelling and encoding Therapeutic Guidelines: applying ICD-10-AM and European Article Number codes. Health Information Management 2004; 32: 51-58. • Harvey K. Free Trade and the Cost of Medicines. Access 2004: 6; 19-24.

Page 4 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Harvey KJ, Faunce TA Lokuge B, Drahos P. Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme? MJA 2004; 181 256-259. • Harvey K, Kalanj K and Stevanovi R. Croatian Pharmaceutical Sector Reform Project: Rational Drug Use. CMJ 2004; 45: 611-619. • Harvey K. Patents, pills and politics: the Australia–United States Free Trade Agreement and the Pharmaceutical Benefits Scheme. Aust Health Rev 2004; 28 (2): 218-226. • Harvey KJ. The Pharmaceutical Benefits Scheme 2003–2004. Australia and New Zealand Health Policy 2005, 2:2. • Harvey KJ, Vitry AI, Roughead E, et al. Pharmaceutical advertising in prescribing software: an analysis. MJA 2005; 183: 75-79. • Bader R, Mawajdeh S, Harvey K. Workshop boosts rational use activities in Jordan. WHO Essential Drugs Monitor 2005; 34: 22-23. • Zhang Y, Harvey KJ. Rational antibiotic use in China: lessons learnt through introducing surgeons to Australian guidelines. Australia and New Zealand Health Policy 2006; 3 :5- 17. • Harvey K. Pharmaceutical Advertisements in Prescribing Software: What Should be Done? Health Issues, 2006; 87: 11-15. • Faunce TA, Lofgren H, Harvey K, Johnston K. Tendering for Low Cost Generics in Australia. Health Issues, 2006; Number 87: 26-29. • Harvey K. Changes in Pharmaceutical Policy over the last 20 Years. Health Issues 2006; 89: 32-38. • Harvey KJ, Harris AH, Bulfone L. The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture? MJA 2007; 187 (4): 206-207. • Harvey KJ, Korczak VS, Marron LJ, Newgreen DB. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia. MJA 2008; 188 (1): 21-25. • Harvey K. Does CM need reform? J Comp Med 2008; 7(3): 37. • Harvey K. Australian Complementary Medicine Regulation: Time for Reform! Health Issues 2009; 5: 18-22. • Harvey K. A review of proposals to reform the regulation of complementary medicines. Aust Health Rev 2009: 33(2); 279-285. • Sweidan M, Williamson M, Reeve JF, Harvey KJ O'Neill JA, Schattner O, Snowdon T. Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process. BMC Medical Informatics and Decision Making 2010; 10:21. • Harvey K. Alternative treatments for impotence. Diabetes Management Journal 2010; 32: 20. • Harvey K, Stough C. Caution with complementaries for cognitive impairment. Aust Prescr 2011; 34: 19-21. • Sweidan M, Williamson M, Reeve JF, Harvey K, O'Neill JA, Schattner P, Snowdon T. Evaluation of features to support safety and quality in general practice clinical software. BMC Medical Informatics and Decision Making 2011, 11:27. • Harvey K. “I want to consume this product; should public health experts stop me?” — Yes. MJA 2011; 195 (7): 378. • Harvey K. Transparency and the Therapeutic Goods Administration. Aust Prescr 2013; 36:110-1 • Harvey K. The Bitter Pill: Is Chemmart’s myDNA Test Right for You? Australasian Science, April 2016. • Harvey K. A critical appraisal of evidence and arguments used by Australian chiropractors to promote therapeutic interventions. Chiropractic Journal of Australia, Volume 44, Number 3, September 2016. • Harvey K, Diug B. Editorial: Retail Genetics. Aust Prescr 2017;40:86-7. https://www.nps.org.au/australian-prescriber/articles/retail-genetics • Harvey, K. (2017), Regulation of complementary medicines. Intern Med J, 47: 983– 985. doi:10.1111/imj.13548 • Harvey K, Diug B. Editorial: The value of food fortification as a public health intervention. Med J Aust 2018; 208 (3): 111-112. doi: 10.5694/mja17.01095.

Page 5 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

https://www.mja.com.au/journal/2018/208/3/value-food-fortification-public-health- intervention • Vickers M, Harvey K. Complementary medicines advertising policy Part I: unethical conduct in the Australian market before July 2018. Aust Health Rev 2020; doi:10.1071/AH19267 • Harvey KJ, Vickers M, Arnold BB. Complementary medicines advertising policy Part II: unethical conduct in the Australian market after July 2018; Aust Health Rev 2020; doi:10.1071/AH20047 Letters to the • Harvey K. Heed evidence. Letter to The Age Oct 02, 2017 Editor (recent) • Harvey K, et al. A triple cash burner. Letter to The Australian. Feb 16, 2018 • Harvey K. Spotlight on regulators. Letter to The Age, Sept 5, 2018. • Harvey K. Probiotic doubts. Letter to The Age, Oct 30. 2018. • Harvey K. Dangerous practices. Letter to The Age, 22 February 2019. • Harvey K. Compensation scheme lacking. Letter to The Age, April 14, 2021 Commissioned • Harvey K, Clark R. A Mechanism for the Development, Implementation and reports (1995-) Evaluation of Evidence-Based, Best-Practice Clinical Guidelines to Facilitate Quality Use of Pathology Tests. The Quality Use of Pathology Committee (QUPC), 2002. • Harvey K. A Process for Developing Evidence Based Treatment Guidelines. Report 6.4, Reform of the Croatian Pharmaceutical Sector Project, Ministry of Health of the Republic of Croatia & Australian Health Insurance Commission, 2003. • Victorian Hospitals Electronic Prescribing and Decision Support Group (Harvey K, Editor). Electronic Medication Management. Victorian Drug Usage Advisory Committee, Melbourne, 2003. • Harvey K. Linking Therapeutic Guidelines with the Primary Health Care Information Technology Project. Report 6.5 Reform of the Croatian Pharmaceutical Sector Project, Ministry of Health of the Republic of Croatia & Australian Health Insurance Commission, 2003. • Harvey K. Guidelines for Assessing Future Projects under the Quality Use of Pathology (QUP) Program. Commonwealth Department of Health & Aging, 2004. • Harvey K, McCauley V, MacIsaac P, Lewis B. Refinement of the HL7 Australia EDS Work plan: A report for the Australian Health Information Council Electronic Decision Support Steering Committee. HL7 Australia 2004. • Harvey K. Deliverable 5: Methodology for the Development of Standard Treatment Guidelines. Jordan Health Sector Reform Project, Jordan Food & Drug Administration & Australian Health Insurance Commission, 2004. • Harvey K. Deliverable 9: Study of Prescribing Practices. Jordan Health Sector Reform Project, Jordan Food & Drug Administration & Australian Health Insurance Commission, 2004. • Harvey K. Critical assessment of Jordan RDU EDL within the International context. PHRplus, Amman, Jordan, August 2005. • Medicare Australia Consultancy. An Economic & Equity Impact Review of National Pharmaceutical System Models. Pharmaceutical Reform Working Group Steering Committee, 2006. • Harvey K. Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013, April 17, 2013. • Harvey K. Melbourne Senate Public Hearing: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill, April 29, 2013. • Harvey K. ACCC - Medicines Australia Limited - Revocation and Substitution - A91436 - A91440, July 22, 2014. • Harvey K. Submission to Expert Review of Medicines and Medical Devices Regulation - Complementary Medicines, April 8, 2015. • Harvey K. Submission to Parliament of Victoria, Legal and Social Issues Committee, Inquiry into End of Life Choices on behalf of Doctors for Voluntary Euthanasia Choice, Oct 15. 2015. • Harvey K, Asher A. Background Paper. The Advertising of Therapeutic Goods and Services (and its Regulation) for Health-Law Seminar, Sydney University, March 17, 2016. • Harvey K. Proposed changes to the Therapeutic Goods Advertising Code. TGACC

Page 6 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

Meeting, Sydney, August 26, 2016. • Harvey KJ, Hall S, Moutafis T. TGA Consultation: The Regulatory Framework for Advertising Therapeutic Goods. School of Public Health and Preventative Medicine, Monash University, 12 December 2016. • Harvey K, Ranaweera P. TGA Consultation: Reforms to The Regulatory Framework for Complementary Medicines - Assessment Pathways. 28 March 2017. • Harvey K, Ranaweera P. TGA Consultation Submission: Options for the future regulation of “low risk” products. 12 May 2017. • Harvey K, Ranaweera P. TGA Consultation Submission: Draft list of permitted indications. 13 Sept 2017. • Harvey K, Ranaweera P Kay E. TGA Consultation Submission: Therapeutic goods advertising code. 13 October 2017. • Harvey K, Braithwaite J, Senate Community Affairs Legislation Committee Submission: Concerns about the Exposure Draft of Therapeutic Goods Amendment (2017 Measures No. 1) Bill and related measures. 12 Dec 2017 • Harvey K, Vickers M, Rottler A. TGA Consultation Submission: Draft Therapeutic Goods Advertising Code 2018 and Associated Guidelines. 27 April 2018 • Harvey K, Vickers M, Rottler A. TGA Consultation Submission: Proposed therapeutic goods advertising code guidance. 4 Oct 2018 • Harvey K. Invited submission to Complementary Health Care Taskforce (Made in Australia controversy), 25 February 2019. • Harvey K. Invited submission to FSANZ, Consumer and Public Health Dialogue, Food-Medicine Interface Problems, 27 March 2019. • Harvey K. Invited submission to ThinkPlace – TGA Advertising Complaints Business Process Improvement Suggestions, 22 May 2020. • Harvey K. TGACC Consultation on amendment to the testimonial provision in the Therapeutic Goods Advertising Code - Choice Response, 25 June 2020 • Harvey K. Daft report on the Therapeutic Goods Advertising Framework (Rosemary Sinclair) – Choice Response, 24 June 2020 • Harvey K. Invited submission to Complementary Health Care Taskforce (Made in Australia controversy), 22 February 2019. • Harvey K. Invited submission to FSANZ, Consumer and Public Health Dialogue, Food-Medicine Interface Problems, 27 March 2019. • Harvey K. Invited submission to ThinkPlace – TGA Advertising Complaints Business Process Improvement Suggestions, 22 May 2020. • Harvey K. TGACC Consultation on amendment to the testimonial provision in the Therapeutic Goods Advertising Code - Choice Response, 25 June 2020 • Harvey K. Daft report on the Therapeutic Goods Advertising Framework (Rosemary Sinclair) – Choice Response, 24 June 2020 • Harvey K. TGACC Meeting 27 August 2020 - Follow up response requested, 10 September 2020. Conference • Harvey, K. The National Manual of QUM Indicators. Pharmaceutical Education Program, proceedings &/or 1995 Work in Progress Conference Proceedings, Commonwealth Department of Health presentations and Family Services, 1996, 14. (1995-) • Harvey, K. The way forward. Pharmaceutical Education Program, 1995 Work in Progress Conference Proceedings, Commonwealth Department of Health and Family Services, 1996, 36. • Harvey K, Nolan A, Dartnell J. Deconstructing Therapeutic Guidelines: from printed books to computerised decision support systems. ASCEPT conference proceedings, • Canberra, 1997. • Norquay C, Dartnell J, Phanouvong S, Harvey K, Hemming M. Moving from the known to the unknown: From print to electronic Therapeutic Guidelines. ASCEPT conference proceedings, Hobart, 1998. • McKinnon R, Harvey K. Containing Vancomycin-resistant Enterococci: Strategies for Victoria. (Conference Report) Victorian Drug Usage Advisory Committee, Melbourne, 1999 • Harvey K. Teledisaster? A case study of the recently abandoned Commonwealth Therapeutic Health Information Project. Australian & New Zealand Health Services

Page 7 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

Research Conference, 1999. • Harvey K. From optimising antibiotic use to involvement in national medicinal drug and health IT policy: issues relevant to decision support. General Practice Computing Group Electronic Decision Support Workshop, Canberra, 1999. • Harvey K. Exporting Australian E-Health Expertise. AIC Worldwide Conferences E- Health, Sydney, 1999. • Harvey K. Therapeutic Knowledge Databases. SPIRT Pharmaceutical Decision Support Workshop, Melbourne, 2000 • Harvey K. SPIRT Pharmaceutical Decision Support Workshop. School of Information Technology & Mathematical Sciences, University of Ballarat, March 2000. • Harvey K. Medication Management 2000: e-Promotion, e-Scripts, e-Health? 2nd International Primary Health Care Conference, Melbourne April 2000 • Harvey K. Pharmaceutical Decision Support Systems. International Workshop on Enterprise Networking and Computing in HealthCare Industry (Healthcom 2000), Sydney, April 2000. • Harvey K. The Doctors Assistant: Decision Support. Mornington Peninsular Division of General Practice, IT-Expo, 13-14th May 2000 • Harvey K. Information for Decision Support: Therapeutics. NHIMAC National Health Online Summit, 3-4 August 2000. • Harvey K. Pharmaceutical Decision Support. Victorian Society of Hospital pharmacists of Australia, 11 November, 2000. • Harvey K. Tensions in Australian Medicinal Drug Policy: The Pharmaceutical Benefits Advisory Committee Controversy. 2nd bilateral research conference, Ateneo de Manila University – La Trobe University, April 18-20, 2001 • Harvey K. National Antibiotic Summit, Sydney. Workshop discussant, 30 to 31 May, 2001. • Harvey K, “Experts at Risk: The Role of Advocacy and Science in the Development of Public Health Policy: The PBAC controversy”. Public Health Association of Australia, ACT Branch, University House, Australian National University, 18 June 2001. • Harvey K. Recent controversies surrounding the Australian Pharmaceutical Benefits Scheme (PBS) IIR s E-PHARMA Conference, Meridian Hotel, Sydney, 27- 29 June 2001. • Harvey K. How TNCs shape Consumer Culture: The Case of Pharmaceuticals. Asia Pacific Research Network (APRN) Conference - Corporate Power or Peoples Power: TNCs and Globalization, Sydney, 27 September 2001 • Harvey K. Risky Business: Improving Antibiotic Use in Australia. Keynote Address. Victorian Infection Control Practitioners Association (VICPA) Conference, 15 November 2001. • Harvey K. Pharmaceutical Decision Support. E-Health Workshop for Health Professionals. La Trobe University, 23 November 2001. • Harvey K. TRIPS & Pharmaceuticals in a public forum on GATS, TRIPS, Globalisation and Public Health. The Victorian Public Health Association and VicHealth, 14 March 2002. • Harvey K. Pharmaceutical Decision Support, GnuMed conference, Lismore, NSW, 25-27 May 2002. • Harvey KJ. Meet a therapeutic guideline activist – Meet the Expert Session, Improving Medication Management Workshop, Department of Human Services, Melbourne, November 2002 • Harvey KJ. Patient safety and clinical risk management: the challenge of implementing computerised prescribing and decision support systems. Key Note Address. Society of Hospital Pharmacists of Australia Victorian State Branch Conference, Bendigo, November 2002. • Harvey KJ, Zhang Y, Antibiotic resistance. Infection Control Seminar, Gippsland Regional Infection Control Group, La Trobe Valley Hospital, Traralgon, November 2002. • Harvey K. Resistance to Antibiotics. ABC Radio National Perspective, Thursday 12 December at 5:55pm. • Harvey K. Meet the Expert (Therapeutic Guidelines). Improving Medication Management Workshop. Quality and Care Continuity Branch Metropolitan Health and Aged Care Division, Department of Human Services, November 2002. • Harvey K. Update on Decision Support and Guideline representation from HL7,

Page 8 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

Cleveland. Austin Hospital Informatics – Work In Progress Seminar, June 2003. • Harvey K. Saving the Pharmaceutical Benefits System. Fabians Society & Doctors Reform Society, Trades Hall, Melbourne, June 2003. • Harvey K. Decision Support Tutorial (invited) Health Informatics Conference, Sydney, August 2003. • Harvey K (panel member). The Future of Open Knowledge in General Practice. GPCG Forum, Sydney, August 2003. • Harvey K. The Need for Decisions Support Standards - a User Perspective. HL7 Australia Decision Support Conference, Sydney, August 2003. • Harvey K. Antibiotic resistance. Infection Control Seminar, Gippsland Regional Infection Control Group, Warrigal, November 2003. • Harvey K. Saving the Pharmaceutical Benefits System. Health Economic Unit, Monash University, Seminar, December 2003. • Harvey K. (Co-Chair) Workshop background. HL7 Australia & New Zealand, Clinical Decision Support Workshop, December 2003. • Harvey K. The Croatian Pharmaceutical Reform Project. School of Public Health Seminar Series, March 2004. • Harvey K. The FTA and the PBS: Public Health & Consumer Concerns. Fabians and Doctors Reform Society, Melbourne, July 2004. • Harvey K. International experience with rational drug use. Jordan Food & Drug Administration, Rational drug use workshop, Marriott Hotel, Dead Sea, September, 2004. • Harvey K. Impact of E-Prescribing on Antibiotic Use in Australia. American Society of Microbiology Annual Meeting on Infectious Diseases (ICAAC 2004), Washington USA, October 2004. • Harvey K. The Australian Pharmaceutical Benefits Scheme 1994-2004. United States Pharmacopeia, Rockville, USA, November 2004. • Harvey K. Will the AUSFTA undermine the PBS? Society of Hospital Pharmacists of Australia, Victorian Branch, November 2004. • Harvey K. Cost containment in Pharmaceutical Benefit Scheme, Australia at International Conference on Cost Containment in National Health Insurance System, Chaingmai, Thailand, 25-25 February 2005. • Harvey K. Pharmaceutical promotion in prescribing software: an analysis. La Trobe University, School of Public Health Research Seminar, March 2, 2005. • Harvey K. The PBS and Quality Use of Medicines, Medication Management Review Workshop, La Trobe University, Bendigo, March 19, 2005. • Harvey K. Free markets and medical software. Fabian Society, Victorian Trades Hall, April 6 2005. • Harvey K. Promotional practices: the need for action. Asia Health Forum, Universiti Sains Malayia, Penang April 26, 2005 • Harvey K. Is the PBS sustainable? Current problems; possible solutions? ALP Hawthorn Branch, May 4, 2005; also Australian College of Pharmacy, Victorian Fellows Dinner, May 19, 2005. • Harvey K. Profit driven research: The problems. Cabrini Hospital Human Research Ethics Committee Seminar, Who Profits from Research? Malvern, June 2, 2005. • Harvey K, Critical assessment of Jordan’s RDU & EDL within the International context. National Workshop on Progress in Jordan National Drug Policy / Towards Implementing an Essential Drug List, Amman, Jordan, July 2, 2005. • Harvey KJ (Session Moderator & Lead Presenter). Pharmaceutical promotion in medical software. Health Informatics Conference August 2, 2005. • Harvey K. Does pharmaceutical marketing unbalance the PBS? 3rd Future of the PBS Conference, Informa, August 25, 2005. • Harvey K. Free Markets and Medical Software. Monash Department of Epidemiology and Preventative Medicine Research Seminar, September 21, 2005. • Harvey K. From Victorian State Antibiotic Guidelines to Australian Quality Use of Medicines Policy &The Australian Pharmaceutical Benefits Scheme: Ensuring equitable access to necessary medicines for rich and poor. 2nd National Workshop on Rational Use of Antibiotics in China, Beijing, November 28-30, 2005. • Harvey K. Curbing Pharmaceutical Promotion: (fighting the commercialisation of health).

Page 9 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

HAIAP Seminar, GK, Dhaka, Bangladesh, April 10-12, 2006. • Harvey K. The reporting of medicines in the media: research findings. National Prescribing Service Seminar for Health and Medical Writers, Sydney, May 3, Canberra, May 31, 2006. • Harvey K. Electronic medication management. 2nd Annual eHealth Conference, 31st July-2nd August, 2006. • Harvey K, Sweet G, Horsfall B. Evidence vs hype: informing better prescribing. National Prescribing Service Dandenong - District Division of General Practice, May 6, 2006, June 20, 2006; Greater South Eastern Division of General Practice, August 30, September 4, 6, 28, 2006. • Harvey K. Australian Private Health Insurance: Inclusive and Equitable? International Society for Equity in Health Meeting, Adelaide September 11, 2006. • Harvey K. Drug Formularies and Rational Drug Use; The Role of Pharmacy & Therapeutic Committees; Drug Evaluation. Jordan National Drug Formulary Dissemination and Implementation Strategy Workshop & PTC Training Workshops, Amman, Jordan, September 18-20, 2006 • Harvey K. Complementary therapies: What every consumer with a chronic illness should know. Chronic Illness Alliance AGM, 13 December 2006. • Harvey K. Private Health Insurance Controversies. U3A Hawthorn Summer School, 12 January 2007, U3A Stonnington, 28 March, 2007. • Harvey K. A Sustainable Pharmaceutical Benefits Scheme. U3A Hawthorn Summer School, 19 January 2007, U3A Stonnington, 4 April, 2007. • Harvey K. Electronic Health Records. U3A Hawthorn Summer School, 26 January 2007, U3A Stonnington, 11 April, 2007. • Harvey K. The 4th Annual Future of the PBS Conference. Conference Chair & Changes in health: a snapshot on prevalent therapeutic drug requirements - Informa Pty. Ltd. 30 April, 2007. • Harvey K. Antibiotic resistance and antibiotic use. Monash Medical School. R1, May 18, 2007. • Harvey K. Complementary and alternative therapies. U3A Manningham, July 23, 2007. • Harvey K, Korczak V, Marron L, Newgreen D. Complementary Medicine: Commercialism, choice and consumer protection. School of Public Health Research Seminar, La Trobe University, 15 August, 2007. • Harvey K. Debating Globalisation: Medicinal Drug Policy. Menzies College, La Trobe University, August 20, 2007. • Harvey K. The Crises in Health Funding – Sustainability of the PBS. Yarra Valley U3A, La Trobe University, September 27, 2007. • Harvey K. Medicinal Drug Policy. Flinders University, Adelaide, October 19, 2007. • Harvey K. Complementary Medicine: Commercialism, choice and consumer protection. U3A Hawthorn Summer School, January 16, 2008. • Harvey K. Transparency and the PBS. 5th Annual Future of the PBS Conference, Informa, May 6, 2008. • Harvey K. Complementary Medicine Reform, National Medicines Symposium, May 16, 2008. • Harvey K. Complementary Medicine Reform. Blackmores, Sydney, June 17, 2008. • Harvey K. Complementary Medicine Reform. St. Vincent's Hospital, Sydney, August 15, • 2008. • Harvey K. Australia-US Free Trade Agreement and the PBS. HAIAP, Bangkok, August 25, 2008. • Harvey K. E-Health, Patients and Ethics. HIC08, Melbourne, Sept 1, 2008. • Harvey K. Regulation of Complementary Medicines, MCHR Seminar, Oct 22, 2008. • Harvey K. Perceptions of the pharmaceutical industry. GSK Executive & staff seminars, Feb 17, 2009. • Harvey K. Complementary Medicine Reform. Therapeutic Expert Advisory Group, RACP, Mar 3, 2009. • Harvey K. Antibiotic resistance and antibiotic use. Monash Medical School, May 22, 2009 • Harvey K. Perceptions of the pharmaceutical industry. Pharma Phact, University of

Page 10 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

Melbourne, Aug 17, 2009 • Harvey K. Educational initiatives to improve rational drug use. HAIAP, Negombo, Sri Lanka, Aug 25, 2009 • Harvey K. Antibiotic resistance and rational antibiotic use. VMPF Country education Program, Sale, Aug 20; Stawell, Sept 7, 2009 • Harvey K. Controlling unethical promotion: has the Australian approach worked? Health Skepticism Meeting, Adelaide, Sept 24, 2009 • Harvey K. Rational Drug Use in Australia: the Role of the National Prescribing Service. APPA2009, Shanghai, Oct 16, 2009 • Harvey K. Complementary Medicines: The need for reform. Dromana Skeptics, Oct 22, 2009. • Harvey K. Perceptions of the pharmaceutical industry. Sanofi-aventis seminar, Nov 5, 2009 • Harvey K. Antibiotic resistance and rational antibiotic use. VMPF Country education Program, Warrnambool Feb 25, Colac April 14, Albury June 25, Leongatha , Sept 15 2010 • Harvey K. Shonky Medical Devices: a preliminary report. U3A Hawthorn, March 12, 2010 • Harvey K. Complementary Medicines Regulation. Swinburne University, April 22, 2010- 08-10. • Harvey K. Why the push for a single code system? ASMI, Sydney, May 4, 2010 • Harvey K. Antibiotic resistance and rational antibiotic use. Monash Medical School, May 25, 2010. • Harvey K. Health Activism in Australia: Pharmaceutical Promotion. HAI Europe / Global, Amsterdam, October 5, 2010 • Harvey K. Critical Appraisal of Drug Company Promotional Techniques. PAC10, Melbourne, October 31, 2010 • Harvey K. Great debate: Pharmacists Should Only Sell Evidence Based Products. PAC10, Melbourne, October 31, 2010. • Harvey K. International Relations and Pharmaceuticals. La Trobe University, International Health Relations, February 19, 2011. • Harvey K. Global Health and Pharmaceuticals. Monash University, March 18, 2011. • Harvey K. Advertising issues. TGA Transparency Review Panel Meeting, March 23, 2011. • Harvey K. Current regulatory landscape. DTCA Workshop, Sydney, April 20, 2011. • Harvey K. Your TGA? Skeptics Victoria, La Notte, June 12, 2011 • Harvey K. War stories of a health activist. ANZAAS Science Talk, July 20, 2011. • Harvey K. SensaSlim, SLAPP writs, the CRP, TGA and the ACCC. Mordi Skeptics. August 2, 2011. • Harvey K. Complementary Medicine Reform and Workshop: Evaluating Evidence: Submitting Complaints. SA Adelaide. August 7, 2011. • Harvey K. My perspective on recent reviews. Medicines, Health Technologies and Reform Workshop, Canberra August 29, 2011. • Harvey K. Health Activism: The SensaSlim Saga. HAIAP, Penang, Malaysia, Sept 5, 2011. • Harvey K. Health Activism: SensaSlim, Civil Society and the TGA. USM DSAP Seminar, Penang, Malaysia, Sept 9, 2011. • Harvey K. SensaSlim Update. Skeptics Groups of Victoria, La Notte, Jan 29, 2012. • Harvey K. The Regulation of Complementary Medicines: a consumer perspective. Centre for Human Psychopharmacology, Swinburne University, Feb 6, 2012. • Harvey K. Evidence Based Complementary Medicines. Pharmaceutical Society of Australia Continuing Education, Monash Medical Centre, Feb 8, 2012; Balwyn High School, Mar 21, 2012. • Harvey K. International Relations and Pharmaceuticals. La Trobe University City cam- pus, Feb 18, 2012. • Harvey K. TGA Reform: the Impact of Civil Society Activism. Victorian Skeptics, La Notte, Feb 20, 2012. • Harvey K. Lifting the evidence base: CMQUM. APP 2012, Sofitel Gold Coast, March 10,

Page 11 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

2012. • Harvey K. Regulatory Reform of Complementary Medicines. Monash University Pharmacology Department, April 30, 2012. • Harvey K, Ratten R, Rea J. Flamed or Defamed: Reducing the Risk for Academics Contributing to Online Debates. La Trobe University, School of Public Health, April 2, 2012. • Harvey K. Improving the Evidence Base for Complementary Medicines. NPS Board Presentation, May 4, 2012. • Harvey K, Basser S, Golden I. Public Lecture: Medicine and Homeopathy. University of Melbourne Medical School, May 10, 2012. • Harvey K. Kaur S (Convenors). Workshop 8, Advertising and promotion. Australian Pacific Conference National Medicines Policy, May 26-29, 2012. • Harvey K. Perceptions of the pharmaceutical industry. Pfizer staff seminar, May 30, 2012 • Harvey K. Improving pharmaceutical promotion in Australia. NPS NMS and APCNMP 2012, May 2012. • Harvey K, Monk D. Industry self-regulation and consumer input. Australian Pharmaceutical Physicians Association (APPA), June 20, 2012. • Harvey K. Self-regulation versus co-regulation: A consumer perspective. 5th Annual Pharmaceutical Law Conference, Sydney 26-27 Jul, 2012. • Harvey K. Perceptions of the pharmaceutical industry. Eli Lilly seminar, August 21, 2012. • Harvey K. Immunizing students against irrational prescribing, Guidelines development: opportunities and challenges, Improving prescribing practice in hospitals: an Australian story, Resisting promotional pressures of industry, Containing Antibiotic Resistance: a World Wide Challenge, Why should we become health activists? AIMST University, Malaysia, 25-28 Sept 2012. • Harvey K. Rational Pharmaceutical Policy. La Trobe University City campus, Oct 3, 2012. • Harvey K. Science versus snake oil: distinguishing evidence-based therapies from the rest. “Riding the wave conference”, Bond University Australia, Oct 6, 2012. • Harvey K. TGA Complementary Medicines Reforms. Australian Naturopathic Practitioners Association, October 28, 2012. • Harvey K, Lundin L. Functional foods & nutraceuticals: Good for your health or fad? Panel discussion, AusFoodTeck, November 2, 2012. • Harvey K. Complementary medicines: sorting the evidence-based wheat from the promotional chaff. Strathmore Rotary Club, Essendon, November 7, 2012 • Harvey K. Confessions of a Serial (Therapeutic Goods) Complainant. Australian Skeptic National Convention December 1-2, 2012. • Roller L, Harvey K. Homoeopathy. Ballarat Skeptics Jan 31, 2013. • Harvey K. International Relations and Pharmaceuticals. La Trobe University City cam- pus, Feb 9, 2013. • Harvey K. Snake oil trumps science: the failure of regulation to protect consumers from shonky complementary and alternative medicine. Malcolm Schonell Memorial Lecture, St George Hospital, Feb 14, 2013. • Harvey K. Self-regulation versus co-regulation: A consumer perspective. ARCS Melbourne Regional Networking Group, April 9, 2013. • Harvey K. Complementary Medicine: Choice, commerce and consumer protection. Lyceum Club, Science and Medicine Circle, April 22, 2013. • Harvey L. Health Activism. ANZCA, Faculty of Pain Medicine, Refresher Day, May 3, 2013. • Harvey K. Complementary Medicine: Rational choice or regulatory failure. Humanist Society of Victoria, May 23, 2013. • Harvey K. TGA regulatory reform: an update. Mordi Skeptics in the Pub, June 4, 2013. • Harvey K. Listed Complementary Medicines: A consumer perspective. Session W15: Sydney ARCS Scientific Congress, 5-6 June 2013 • Harvey K. Regulatory Reforms: a health activist’s perspective. TGA Professional staff, Symonston, ACT, July 24, 2013. • Harvey K. K. Regulatory Reforms: a health activist’s perspective. Retired Pharmacists Group, Pharmacy College, Parkville, July 30, 2013.

Page 12 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Harvey K. TGA (and related) regulatory reform: an update. Department of Epidemiology & Preventive Medicine, Monash University, August 13, 2013. • Harvey K. Health professions & therapeutic goods industry: Regulatory / ethical issues & Complementary Medicine: Choice, commerce & consumer protection. ACCP Annual Conference, Melbourne, August 23-25, 2013. • Harvey K. Health professions & therapeutic goods industry: Regulatory / ethical update. Skeptics Groups of Victoria, La Notte, Sept 1, 2013. • Harvey K. Evidence based medicine: Case studies. St Vincent’s Hospital Med 2 students, Sept 6, 2013. • Harvey K. It takes two to tango: ethical dilemmas of health professionals and the therapeutic goods industry. Australian Medical Students’ Association (AMSA) Global Health Conference, Hobart, September 12-15, 2013. • Harvey K. Rational Pharmaceutical Policy: National Medicines Policy. La Trobe University Health Policy Analysis, Sept 25, 2013. • Harvey K. Supplement claims: are they warranted? SDA-AIS Supplement Symposium, Canberra, Feb 13-14, 2014 • Harvey K. Career development: Reflections of a health activist. WEHI Student Retreat, Hepburn Springs, April 4, 2014 • Harvey K. Complementary Medicine Reform: NTRAC, TGA, etc. Monash University, School of Public Health and Preventive Medicine Seminar, June 18, 2014. • Harvey K. Complementary Medicine: Exploring the Issues. U3A Melbourne, Short Course (3 sessions), June-July 2014, National Seniors Centre. • Harvey K. Complementary and alternative medicines: Q&A. Masters students in Science & Public Policy, Australian National University, Oct 7, 2014. • Harvey K. Australian National Drug Policy. Talk to visitors from Ministry of Health Malaysia, Pharmaceutical Services Division at La Trobe University, Oct 13, 2014 • Harvey K. Complementary Medicine: Exploring the Issues. U3A Melbourne Short Course (3 sessions), Nov 2014, Multicultural Hub • Harvey K. Bachelor degrees for Homeopathy: the role of TEQSA. Mordi Skeptics, Mordialloc, Vic, Feb 3, 2015. • Harvey K. Complementary Medicine: Exploring the Issues. Somers Combined Probus Club, May 8, 2015. • Harvey K. Health Care Interventions: Choosing Wisely. U3A Melbourne City Short Course GAA House (8 sessions), April-June 2015. • Harvey K. Complementary Medicine: Exploring the Issues. U3A Melbourne City Short Course GAA House (3 sessions), June-July 2015. • Harvey K. The 'No Advertising Please' Campaign: Therapeutic Goods & Ethical Dilemmas. AMSA National Convention, Melbourne, July 6, 2015. • Harvey K. Complementary Medicine: Exploring the Issues. The Bays Aged Care Facility (Pink Ladies Inc.), Hastings, Oct 22, 2015. • Harvey K. Health Care Interventions: Choosing Wisely. U3A Melbourne City Short Course GAA House (8 sessions), Oct-Nov 2015. • Harvey K. The advertising of therapeutic goods and services (and its regulation). Mordi Skeptics, March 1, 2016. • Harvey K. AHPRA Chiropractic Case Study. Sydney University Health-Law Seminar, March 17, 2016. • Harvey K. Medicine, Media and the Law: Reflections of a Health Activist. SPHPM Physicians Peer Review QI Group, May 2, 2016. • Harvey K, Vitry A, Mintzes B. Reinvigorating the regulation of therapeutic goods advertising to consumers. NMS 2016, Canberra, May 19, 2016. • Harvey K, Dwyer J. AHPRA-CBA Stakeholder Forum: Friends of Science in Medicine Presentation. Park Royal Hotel, Melbourne Airport, July 28, 2016. • Harvey K. Drug promotion, advertising and ethical relationships with industry. Monash University Pharmacology: PHA2022 - Drugs and Society, August 16, 2016 • Harvey K. The advertising of therapeutic goods and services (and its regulation). Monash BMedSci BMS3052, August 22, 2016. • Harvey K. Agenda Item 15: Proposed changes to the Therapeutic Goods Advertising Code. TGACC Meeting, Sydney, August 26, 2016.

Page 13 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Harvey K. The 2015 Review of Medicines and Medical Devices Regulation: Government Response. Informa, PharmaLaw Conference, Sydney Sept 1, 2016. • Harvey K. Improving controls on the promotion of therapeutic goods and services in Australia. MPH5272 Reform and development of health Services, Sept 21, 2016 • Harvey K. Antibiotic resistance: the need for innovative global and local policy in response to market failure. University of Queensland, Global Health Conference, Sept 19, 2016. • Harvey K, Hall S, Moutafis T. The “Whack-a-mole” project: How to lodge a complaint about unethical promotion of therapeutic goods and services. University of Melbourne Secular Society Skepticamp, Nov 25, 2016. • Harvey K. Update on reform of Australian complementary medicines and advertising regulation. Skeptics Annual Convention, Melbourne, Nov 26, 2016. • Harvey K. Supplements: Solution or Scandal? Torque Global Health Workshop, April 8, 2017. • Harvey K. Latrobe University Health Policy Analysis: Pharmaceutical Policy, April 25, 2017. • Harvey K. BMS3052, The advertising of therapeutic goods and services (and its regulation), August 8, 2017. • Harvey K. PHA2022, Drugs & Society: Drug promotion, advertising and ethical relationships with industry, August 21, 2017 • Harvey K. Seminar: The Advertising of Therapeutic Goods and Services (and its regulation) - Case study: AMI begat MWI begat AMHC, Monash Law Chambers, September 8, 2017. • Harvey K. MPH5272, Improving controls on the promotion of therapeutic goods and services in Australia. Reform and development of health Services, Sept 20, 2017 • Harvey K. U3A Complementary Medicine: Exploring the Issues (3 sessions GAA House), October 2017. • Harvey K. Australia Awards Fellowship Program, Introduction to the TGA and other bodies involved in Australian Medicines Policy, Nov 2, 2017. • Harvey K. Medicine and the Media: Reflections of a health activist, Nov 25, 2017. • Harvey K. An update on advertising and complementary medicine regulatory reform, Mordi Skeptics in the Pub, December 5, 2017 • Harvey K, Li E, Mackie M, de Carheil G. “Whack‐a‐mole” student work and an update on TGA regulatory reform, Skeptic Café, The Clyde Hotel, December 18, 2017. • Harvey K, Latrobe University PHE5AHR, Australia's International Health Relations, National Medicines Policy: The influence of transnational corporations and other stakeholders, 30 Jan 2018 • Harvey K, Vaux A, Dong M. What Claims Should be Permitted for Therapeutic Goods? Civil Society Hearing on Therapeutic Goods Bill, ANU 24 Jan 2018. • Harvey K. ANU, Health in the 21st Century, BHSc, Antibiotic resistance: the need for innovative global and local policy in response to market failure, 19 March 2018. • Harvey K, Rottler A, Vickers M. Consumer understanding of the regulation of complementary medicines U3A Hawthorn, April 18, 2018. • Harvey K. MPH5272, Complementary Medicine and Advertising Reform Reform and development of health Services, July 25, 2018. • Harvey K. BMS3052, The advertising of therapeutic goods and services (and its regulation), August 6, 2018. • Harvey K. PHA2022, Drugs & Society: Drug promotion, advertising and ethical relationships with industry, August 17, 2018. • Mahady S, Harvey K, Livingstone C, Medew J. Short Course Media Skills for Academics and Clinicians, SPHPM, 31 August 2018. • Harvey K, Skerritt J, Rottler A, Wardle J, Vickers M. APHC 2018 Workshop Contested Policy: Complementary medicines and advertising reform, 26 Sept 2018. • Harvey K. Fighting Antibiotic Resistance in Melbourne Hospitals, 40 Years of Antibiotic Guidelines Anniversary Seminar, Melbourne University, 13 November 2018. • Harvey K, Vickers M, Malek Mary, Cooray, K. Vic Skeptics Café, Complementary Medicines, Advertising Reform and the TGA, 19 November 2018. • Harvey K. Reform of Advertising and Complementary Medicine Regulation, Chronic

Page 14 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

Illness Alliance AGM, 27 November 2018 • Harvey K. Made in Australia: Is it? Complementary Healthcare Taskforce. Department of Industry, Innovation and Science, Canberra, 31 January 2019. • Harvey K. Food-Medicine Interface Problems: The need for reform, FSANZ, Consumer and Public Health Dialogue, Canberra, 27 March 2019. • Harvey K. Complementary medicine regulation. Koonung Bushwalking Club, 17 April 2019. • Harvey K, Vickers M. Australian COVID-19 Scams: The role of regulators. Gold Coast Skeptics in the Pub (Zoom meeting), 18 May 2020 • Harvey K, Sinclair R, Skerritt J, Asher A, Marshall, M, Skepticon 2020, Independent Review of the Australian Therapeutic Goods Advertising Framework Panel session, October 24, 2020 (Session organiser, and presenter, 'Background to the Review'). Other printed • Pilbeam M, Harvey K. Antibiotic advice (letter). Aust Fam Physician 1987; 4: 369-370. publications • Harvey K. PBS charges. (letter) Med J Aust 1991;154: 364-365. • Harvey K. What influences prescribing--scientific articles or promotional pressure? (letter) Med J Aust 1988; 149: 720. • Harvey K. Medicines Information on the net. MediScene Newsletter 1998; 7: 3-4. • Harvey K, Patient records for sale. The Australian Health Consumer 2001; 2:42. • Harvey K. Exploring Electronic Medication Management. INRUD News 2003: 13; 35- 34. • Harvey K. Free Trade and the Cost of Medicines. Access 2004: 6; 19-24. • Schattner P, Harvey K. Computers in General Practice: Module 4, Electronic Resources. General Practice Computer Group 2005 • Harvey K. Rebate is a prescription for lazy healthcare. The Canberra Times. 1 March 2006. http://tinyurl.com/mzl2h • Harvey K. Injunction impedes independent information (letter). Aust Prescr 2007; 30: 33. http://www.australianprescriber.com/magazine/30/2/32/4/ • Pollard NA || Santoro A || Kotsirilos V || Masters CS || Harvey KJ, Korczak VS, Marron LJ and Newgreen DB. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia [letters]. Med J Aust 2008; 189 (1): 50-53. http://www.mja.com.au/public/issues/189_01_070708/letters_070708_fm-2.html • Harvey K. Complementary Medicine: Handle with Care. Issues 2008; 84:7-9. • Harvey J. Homeopathy costs us all. Australasian Science 2010; 31(5): 38. Publication in • ABC Radio National Perspective, Antibiotic Resistance, 12/12/2002. Transcript available other media at: http://www.abc.net.au/rn/talks/perspective/stories/s745380.htm Radio • ABC Radio Australia Talks, July 23, 2008. August 13, 2008 http://www.abc.net.au/rn/australiatalks/stories/2008/2311121.htm • ABC Radio Australia Talks, Complementary medicine. August 13, 2008 http://www.abc.net.au/rn/australiatalks/stories/2008/2332821.htm • ABC Radio Life Matters, Headaches: what’s new? Nov 22, 2010 http://www.abc.net.au/rn/lifematters/stories/2010/3061507.htm • ABC Health Report, Regulation of Complementary Medicines. May 16, 2011 http://www.abc.net.au/rn/healthreport/stories/2011/3215960.htm Film • ABC and BBC Horizon program. The Microbe Masters the Mould. A 50 minute scientific documentary film on antibiotic resistance, 1986. • WHO Drug Action Program. Prescribing rationally, not fashionably. An Australian video produced in association with Dr. Frances Black (RACGP-FMP Educator). An Indian version, Push, Promote or Educate? also produced in association with Prof. CH Shasindran and Prof. KR Sethuraman, of the Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India, 1990. • SBS TV Vitamania, Consultant, 2018 CDROM • Norquay C, Dartnell J, Phanouvong S, Harvey K. (electronic conversion authors) E- Antibiotic Guidelines (HTML Help format) 10th Ed. 1999 Therapeutic Guidelines Ltd., Melbourne 1999. World Wide Web • Coulthart R, Harvey K, et al. ‘The Doctor’s Gravy Train’, Nine Network Australia Sunday (WWW) Program, August 5, 2001 http://news.ninemsn.com.au/sunday/cover_stories/article_896.asp • Harvey K, The Pharmaceutical Benefits Scheme (Nov 2, 2001) Digest

Page 15 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

http://www.australianreview.net/digest/2001/11/harvey.html • Harvey K, Symposium: The 2002-03 Federal Budget - Securing the future of the PBS? (June 3 2002) Digest http://www.australianreview.net/digest/2002/06/harvey.html • Harvey K. Pharmaceutical benefits and free trade: trouble ahead for subsidised medicines in Australia? (March 19, 2004) Digest http://www.australianreview.net/digest/2004/03/harvey.html • Harvey K. Private Health Insurance: Where are we now and where should we be going? 22 February 2006. http://cpd.org.au/article/private-health-insurance%3A-where-are-we- now-and-where-should-we-be-going%3F • Harvey K. The Sale of Medibank Private.1 March 2006. http://cpd.org.au/article/sale- medibank-private • Harvey K. Drug companies' free lunches have expensive side-effects, 4 August, 2006. http://cpd.org.au/article/drug-companies%2526%2523039%3B-free-lunches-have- expensive-side-effects • Harvey K. Policy Change Needed for Complementary Medicines. Insight, August 2008. http://cpd.org.au/article/policy-change-needed-complementary-medicines • Harvey K. et al. Doctors and drugs. SBS Insight 26 May, 2009. http://news.sbs.com.au/insight/episode/index/id • Harvey K. Doctors and drugmakers: are new laws the answer? MJA Insight. 13 September 2010. http://www.mjainsight.com.au/view?post=dr-ken-harvey-doctors-and- drugmakers-are-new-laws-the-answer&post_id=571&cat=comment • Harvey K. Our world depends on investment in antibiotics. MJA Insight. 27 September 2010. http://www.mjainsight.com.au/view?post=ken-harvey-our-world-depends-on- investment-in-antibiotics&post_id=856&cat=comment • Harvey K. The risks from vague medicine labels. MJA Insight. 7 March 2011. http://www.mjainsight.com.au/view?post=ken-harvey-the-risks-from-vague-medicine- labels&post_id=3572&cat=comment • Harvey K. SensaSlim and me: how criticism of a weight-loss spray landed me in court. The Conversation, 20 June, 2011. http://theconversation.edu.au/sensaslim-and-me-how- criticism-of-a-weight-loss-spray-landed-me-in-court-1911 • Harvey K. Some reaction to the transparency review of the TGA. Croaky, July 20, 2011. http://blogs.crikey.com.au/croakey/2011/07/20/some-reaction-to-the-transparency- review-of-the-tga • Harvey K. Surviving the SensaSlim saga. MJA Insight. 29 August 2011. http://www.mjainsight.com.au/view?post=ken-harvey-surviving-the-sensaslim- saga&post_id=5991&cat=comment • Harvey K. The problem with patents and chronic disease ABC Radio Saturday Extra. 24 September 2011. http://www.abc.net.au/rn/saturdayextra/stories/2011/3324321.htm • Harvey K. Pharmacies to push supplements as ‘fries and Coke’ to prescriptions. The Conversation. 27 September 2011. http://theconversation.edu.au/pharmacies-to-push- supplements-as-fries-and-coke-to-prescriptions-3578 • Harvey K. Pills deal comes with its own ills [Opinion]. SMH. Sept 28, 2011. http://www.smh.com.au/opinion/society-and-culture/pills-deal-comes-with-its-own-ills- 20110927-1kvb9.html • Collett M, Harvey K. Controversial Blackmores pharmacy deal withdrawn. ABC News. Oct 6, 2011. http://www.abc.net.au/news/2011-10-06/controversial-blackmores- pharmacy-deal-withdrawn/3317960?section=business • Harvey K. Companion deal raises CM evidence issues. Oct 17. 2011. http://www.medicalobserver.com.au/news/companion-deal-raises-cm-evidence–issues • Harvey K. One wrong foot after another: the ethics of the Pharmacy Guild’s deals. Oct 20, 2011. http://theconversation.edu.au/one-wrong-foot-after-another-the-ethics-of-the- pharmacy-guilds-deals-3939 • Harvey K. TGA all bark no bite as Labor botches response to a series of reviews. Dec 8, 2011. http://theconversation.edu.au/tga-all-bark-no-bite-as-labor-botches-response-to-a- series-of-reviews-4640 • Harvey K, Mares P. ABC Radio National Interest. Health watchdog gets a few more teeth, but still lacks bite. Dec 9, 2011. http://www.abc.net.au/radionational/programs/nationalinterest/health-watchdog-gets-a- few-more-teeth2c-but-still-lacks-bite/3723236

Page 16 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Harvey K. New weight-loss claims show TGA reforms aren’t working. The Conversation, Feb 23, 2012. http://theconversation.edu.au/new-weight-loss-claims-show- tga-reforms- arent-working-5526 • Moses G, Cheney T, Harvey K, Myers S, Tiralongo E, Wardle J. Complementary Medicines: The Best Advice. Rural Health Education Foundation, Feb 28, 2012. http://www.rhef.com.au/programs/program-1/?program_id=580 • Harvey K. CM evidence is testing. MJA Insight, Mar 26, 2012. http://www.mjainsight.com.au/view?post=Ken+Harvey%3A+CM+evidence+is+testing& post_id=8550 • Brennan L, Harvey K. Ethics of accepting suppliers' gifts in the business v medical world. The Conversation, April 12, 2012. • http://theconversation.edu.au/ethics-of-accepting-suppliers-gifts-in-the-business-v- medical-world-3968 • Harvey K. Consumer input in Medicines Australia’s code of conduct review. The Conversation, 16 April, 2012. http://theconversation.edu.au/consumer-input-in- medicines-australias-code-of-conduct-review-6370 • Harvey K. Swisse Vitamins highlights the failure of industry self-regulation. The Conversation, 19 April 2012. http://theconversation.edu.au/swisse-vitamins-highlights- the-failure-of-industry-self-regulation-6535 • Harvey K. Companies tussle over market share for anti-cholesterol drug Lipitor® and its generic equal. The Conversation, May 18, 2012. https://theconversation.edu.au/companies-tussle-over-market-share-for-anti-cholesterol- drug-lipitor-and-its-generic-equal-7088 • Harvey K. It’s worth the hassle. MJA Insight, July 30, 2012. http://www.mjainsight.com.au/view?post=Ken+Harvey%3A+It%E2%80%99s+worth+the +hassle&post_id=10095 • Harvey K. Swisse vitamins’ sweetener to doctors: complaint resolution. The Conversation August 30, 2012. http://theconversation.edu.au/swisse-vitamins-sweetener- to-doctors- complaint-resolution-9158 • Harvey K. TGA, once again, fails to reign in shonky weight-loss product. The Conversation October 22, 2012. http://theconversation.edu.au/tga-once-again-fails-to- reign-in-shonky-weight-loss-product-10227 • Harvey K. Kids Smart’s dumb ads: consumers complain of misleading claims. The Conversation, Oct 30, 2012. http://theconversation.edu.au/kids-smarts-dumb-ads- consumers-complain-of-misleading-claims-9989 • Harvey K. Vital Transparency. MJA Insight, December 3, 2012. http://www.mjainsight.com.au/view?post=ken-harvey-vital- ransparency&post_id=11651&cat=comment • Harvey K. Private health insurers’ natural therapy rebates under spotlight. The Conversation, March 8, 2013. http://theconversation.edu.au/private-health-insurers- natural-therapy-rebates-in-the-spotlight-12706 • Harvey K. Pharmacists should drop products that aren’t backed by evidence. The Conversation, March 21, 2013. https://theconversation.com/pharmacists-should-drop- products-that-arent-backed-by-evidence-12646 • Reucassel C, Harvey K. Complementary Medicines | Ep1 | The Checkout | ABC1 TV | March 21, 2013. http://www.youtube.com/watch?v=nH8GwjLZ9IE • Harvey K. Clear relationships. MJA Insight, April 29, 2013. https://www.mja.com.au/insight/2013/15/ken-harvey-clear-relationships • Harvey K, Voevodin M. Regulations around food-medicine products fail to protect consumers. The Conversation, May 21, 2013. https://theconversation.com/regulations- around-food-medicine-products-fail-to-protect-consumers-14360 • Harvey K. Pharma payments to doctors stay behind closed doors … for now. The Conversation, June 19, 2013. http://theconversation.com/pharma-payments-to-doctors- stay-behind-closed-doors-for-now-15279 • Harvey K. Slow path to transparency. MJA Insight, July 1, 2013. https://www.mja.com.au/insight/2013/24/ken-harvey-slow-path-transparency • Harvey K. Advertising battleground. MJA Insight, July 15, 2013. https://www.mja.com.au/insight/2013/26/ken-harvey-advertising-battleground • Harvey K, Katelaris A. Medical Observer Podcast: CAM regulation and therapeutic goods

Page 17 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

industry transparency, Sept 2, 2013. http://tinyurl.com/l5s9ypv • Harvey K. If I could say one thing, ABC, The Checkout, Episode 7, 3 April 2014, https://www.youtube.com/watch?v=1yBJRs_ZgWk • Harvey K. We can’t have it both ways on homeopathy. ABC The Drum, 10 April 2014,http://www.abc.net.au/news/2014-04-10/harvey-why-are-there-still-accredited- homeopathy-degrees/5378836 • Harvey K. Transparency hurdles. MJA Insight, July 28, 2014, https://www.mja.com.au/insight/2014/27/ken-harvey-transparency-hurdles • Harvey K. Pharmaceutical industry code of conduct fails to find favour. The Conversation, 22 August 2014, https://theconversation.com/pharmaceutical-industry- code-of-conduct-fails-to-find-favour-30404 • Harvey K, Kovacs A, Jackel G. Krill oil marketing: a case study of Australia’s broken regulations. Feb 6, 2015, https://theconversation.com/krill-oil-marketing-a-case-study-of- australias-broken-regulations-36770 • Harvey K. Analysis of Medicines Australia Code Breaches. MJA Insight, March 02, 2015. https://www.mja.com.au/insight/2015/7/ken-harvey-code-breaches • Harvey K. The right touch (regulation of complementary medicines). MJA Insight, • April 27, 2015. • https://www.mja.com.au/insight/2015/15/ken-harvey-right-touch • Komesaroff P & Harvey K. Viewpoints: should universities accept funding from industry (Maurice Blackmore Chair of Integrated Medicine at Sydney University)? The Conversation, May 27, 2015. https://theconversation.com/viewpoints-should-universities- accept-funding-from-industry-42348 • Harvey K. ABC RN Interview - Drug company marketing on doctor's choices, • August 28, 2015.http://www.abc.net.au/radio/programitem/pgYOG2yM17 • Harvey K. Time to act: Aberrant chiropractors must now be held to account for breaches of the law, MJA Insight, Sept 7, 2015. https://www.mja.com.au/insight/2015/34/ken- harvey-time-act • Harvey K, Yan A, Latham, N. Don’t believe the hype – your complementary • medicines are unlikely to deliver, The Conversation, Dec 14, 2015.https://theconversation.com/dont-believe-the-hype-your-complementary-medicines- are-unlikely-to-deliver-52139 • Ken Harvey and Malcolm Vickers: Chiropractic board in firing line, MJA Insight, • Jan 18, 2016.https://www.mja.com.au/insight/2016/1/ken-harvey-and-malcolm-vickers- chiropractic-board-firing-line • Chiropractor watchdog must show some bite. The Age, Jan 18, 2016.http://www.theage.com.au/comment/ken-harvey-20160116-gm7hln • Harvey K, Diug B. Chemmart’s myDNA test offers more than it can deliver. The Conversation, Feb 17, 2016. https://theconversation.com/chemmarts-mydna-test-offers- more-than-it-can-deliver-54484 • Harvey K. Big Vitamin. The Project, 17 May 2016. https://www.youtube.com/watch?v=PiTxulYALoo&feature=youtu.be • Harvey K, Dwyer J. Will chiropractors listen to stakeholder forum? MJA InSight. August 8, 2016. https://www.doctorportal.com.au/mjainsight/2016/30/will- chiropractors-listen- to-stakeholder-forum/ • Harvey K. Recommitting to the sanity of evidence: Acceptance speech upon being awarded the 2016 ANZAAS Medal. MJA Insight, September 5, 2016. https://www.doctorportal.com.au/mjainsight/2016/34/recommitting-to-the-sanity-of- evidence/ • Harvey K. Open debate needed for TGA to regain trust. MJA Insight. Nov 7, 2016. https://www.doctorportal.com.au/mjainsight/2016/43/open-debate-needed-for-tga- to- regain-trust/ • Harvey K, Bartholomew G. Makers of Nurofen will feel no pain from $6 mil fine. ABC News Radio, December 12, 2016. http://mpegmedia.abc.net.au/newsradio/audio/201612/r1649318_25326680.mp3 • Harvey K, Hall S, Moutafis T. Dodgy claims for complementary medicines? Here’s how the drug watchdog could have more bite. The Conversation, December 19, 2016. https://theconversation.com/dodgy-claims-for-complementary-medicines-heres-how-the- drug-watchdog-could-have-more-bite-69488

Page 18 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Harvey K. Call for closer Senate scrutiny on regulation/advertising of complementary medicines. 23 January 2018. https://croakey.org/call-for-closer- senate-scrutiny-on- regulationadvertising-of-complementary-medicines/ • Harvey K, Arnold B. Scrapping pre-approval of medicine ads will put consumers at risk. January 25, 2018. https://theconversation.com/scrapping-pre-approval-of- medicine-ads- will-put-consumers-at-risk-90625 • Harvey K, Dong M, Vaux A, Mustac A. Forum calls for greater protection on claims from complementary medicines, 28 January 2018. https://croakey.org/forum-calls-for-greater- protection-on-misleading-pseudo- scientific-claims-from-complementary-medicines/ • Harvey K, Asher A, Braithwaite J. Tangled web around the TGA (2017 Measures No. 1) Bill 2017. MJA Insight 19 February 2018. https://www.doctorportal.com.au/mjainsight/2018/6/tangled-web-around-the-tga- 2017- measures-no-1-bill-2017/ • Harvey K. Which supplements work? New labels may help separate the wheat from the chaff. The Conversation, February 21, 2017. https://theconversation.com/which- supplements-work-new-labels-may-help-separate-the-wheat-from-the-chaff-73189 • Harvey K. A Current Affair’s “ADHD breakthrough”: bona fide news or unethical advertising? Croaky, March 21, 2017. https://croakey.org/a-current-affairs-adhd- breakthrough-bona-fide-news-or-unethical-advertising/ • Harvey K, Li E, Stanton R, Dashper S. Kids’ vitamin gummies: unhealthy, poorly regulated and exploitative. The Conversation, May 29, 2017. https://theconversation.com/kids-vitamin-gummies-unhealthy-poorly-regulated-and- exploitative-76466 • Harvey K. New complementary medicine health claims lack evidence, so why are they even on the table? The Conversation, July 21, 2017. https://theconversation.com/new- complementary-medicine-health-claims-lack- evidence-so-why-are-they-even-on-the- table-80896 • Harvey K. Science or Snake Oil: will horseradish and garlic really ease a cold? The Conversation, November 27, 2017. https://theconversation.com/science-or-snake- oil- will-horseradish-and-garlic-really-ease-a-cold-87602 • Harvey K, Arnold B. Scrapping pre-approval of medicine ads will put consumers at risk. January 25, 2018. https://theconversation.com/scrapping-pre-approval-of- medicine-ads- will-put-consumers-at-risk-90625 • Harvey K, Asher A, Braithwaite J. Tangled web around the TGA (2017 Measures No. 1) Bill 2017. MJA Insight 19 February 2018. https://www.doctorportal.com.au/mjainsight/2018/6/tangled-web-around-the-tga-2017- measures-no-1-bill-2017/ • Harvey K, Deane J. Science or Snake Oil: do ‘rescue remedies’ ease stress? July 31, 2018. https://theconversation.com/science-or-snake-oil-do-rescue-remedies- ease-stress-89146. • Harvey K Stehlik P. Science or Snake Oil: do hangover cures actually work? November 16, 2018. https://theconversation.com/science-or-snake-oil-do- hangover-cures-actually- work-101033 • Harvey K, et al., NINE 60 Minutes Complementary medicine Extra, Feb 10, 2019, http://www.medreach.com.au/wp- content/uploads/2019/02/60_Minutes_Harvey_Small.mp4 • Harvey K, et al., SBS Insight, Vitamins and Supplements, 12 March 2019, https://www.sbs.com.au/ondemand/video/1448561731545 • Harvey K, et al. SBS The Feed, Session 2019, Episode 7, Cure or Quack, 28 March 2019, https://www.medreach.com.au/sbs-the-feed-session-2019-episode-7-cure-or-quack/ • Harvey K, Watson W, Stanton R. Where food meets medicine: reform needed. MJA Insight 23 April 2019. https://insightplus.mja.com.au/2019/15/where-food-meets- medicine-reform-needed/ • Harvey K. NINE ACA, BergaMet Pro +11 April 2020. https://www.medreach.com.au/wp-content/uploads/2020/04/ACA_BergaMet.mp4 • Harvey K. TGA fails to act on Palmer’s hydroxychloroquine advertisements, Pearls and Irritations, 7 May 2020. https://johnmenadue.com/ken-harvey-tga-fails-to-act-on-palmers- hydroxychloroquine-advertisements/ • Clark P, Somers E, Harvey K. ABC Nightlife, How the pharmaceutical industry works, 11 May 2020. https://www.abc.net.au/radio/programs/nightlife/big-pharma/12236554

Page 19 of 20 Curriculum Vitae - Dr Kenneth John HARVEY

• Harvey K. The Therapeutic Goods Administration must do better. Pearls and Irritations, 10 July 2020. https://johnmenadue.com/ken-harvey-the-therapeutic-goods-administration- fails-again-this-time-on-hangover-products/ • Harvey K. Review of the Therapeutic Goods Advertising Framework. Pearls and Irritations, 15 November 2020. https://johnmenadue.com/review-of-the-therapeutic- goods-advertising-framework/ Supervision • Aaron Kovacs, Grace Jackel, Summer Vacation Scholarship Program, 2014 (Monash only): • Amy Yan, Ned Latham, Summer Vacation Scholarship Program, 2015 • Sasha Hall, Tiana Moutafis, Summer Vacation Scholarship Program, 2016 • Prasad Ranaweera, For Board Certification as Consultant Community Physician of Sri Lanka, 2017 • Amy Vaux, Amy Mustac, Michael Dong, Summer Scholarship Program, 2017 • Alanna Rottler, BMedSc (Hons), 2018 • Darci Bucheli, Lucy Romanoff, Summer Vacation Scholarship Program, 2018 • Mal Vickers, MPH, 2018 • Mary Malek, BMS3990, Semester 2, 2018. • Kithmini Cooray, MB BS, research experience, Semester 2, 2018 • Chiara Piazzese (BMS 2), Chelsea Landwehr (Med 2) and Zoe Nikakis (BMS 2) Monash SPHPM Summer Vacation Scholarship Program 2019 • Aung Oo (BMS 2), Yuet Fonia Wong (BMS 2) and Arghavan Shafiei (BMS 2) Monash BME2032 Work Integrated Learning (WIL) Program • Cameron Powell, MD Scholarly Intensive Program, 2020 • Anjali Kumer, Shuyi Wu, BMS Honours 2020 • Cathey Saha, Delaney Pratt, Lachlan Sim, Work Integrated Learning (WIL) students, 13 - 31 July 2020 • Samantha ELLIOTT, Emmanuella MENSAH, Carlin (Yi) CHEN, Work Integrated Learning (WIL) students 3 August - 30 October 2020 • Selena Duan, Anjana Ravi, Luke Tork, Gace ANG, Work Integrated Learning (WIL) students 3 August - 30 October 2020 Teaching • BMS3052, The advertising of therapeutic goods and services (and its regulation) and (Monash) “Whack-a-mole” project (supervision and marking) • PHA2022, Drugs & Society: Drug promotion, advertising, and ethical relationships with industry, • MPH5272, Improving controls on the promotion of therapeutic goods and services in Australia. Reform and development of health services, • MBBS Prevention Science, Case studies in complementary medicine. Teaching • Antibiotic Resistance (ANU) • The advertising (and regulation) of therapeutic services and goods • Medicinal Drug Policy • Health Activism Teaching • The ‘Whack-a-mole’ project: Ineffective treatments that just won’t go away. (Bond)

Page 20 of 20